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Abstract
Morganella morganii is a gram-negative bacterium from the Enterobacteriaceae family which
causes a wide range of clinical infections sometimes with fatal consequences. It is known that
more than 50% of isolates of M. morganii from clinical specimens have hemolytic activity that
increase  their  virulence.  Pore-forming  toxins  (PFT)  represent  the  most  common  group  of
cytotoxic proteins which contribute the delivering of the bacterial proteins into host cells, loss of
nutrients and ions by eukaryotic cells, as well as the exit of bacteria from phagosome into
cytosol. In this study we investigated the hemolytic activity of two M. morganii strains. It has
been shown that hemolytic activity for strain of M. morganii 4 is 3 times higher than for strain of
M. morganii 1. The maximum hemolytic activity is observed in LB medium but synthesis of
hemolysins is higher in synthetic urine. Finally, the PCR-analysis of 5 hypothetical hemolysin
genes has shown that strain M. morganii 1 does not contain homologous of α-hemolysin from E.
coli that may explain the observed differences in hemolytic activity of the investigated strains.
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